<DOC>
	<DOCNO>NCT01969019</DOCNO>
	<brief_summary>This study design compare efficacy safety 4.5g iv MP administer 12 week 4 week .</brief_summary>
	<brief_title>A Prospective , Randomized Trial Intravenous Pulse Versus Sequential Steroid Therapy Patients With Graves ' Orbitopathy</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Patients meet criterion either b together c , e include study . a. Lid retraction one following : ) Thyroid dysfunction ii ) Proptosis iii ) Optic nerve involvement iv ) Extraocular muscle involvement b. Thyroid dysfunction one following : ) Proptosis ii ) Optic nerve involvement iii ) Extraocular muscle involvement c. Exclude case ophthalmological sign cause disease . d. Moderate severe patient define EUGOGO . e. Clinical activity score ( CAS ) ≥3/7 f. Normal function heart , liver kidney . Orbital decompression surgery need immediately History chronic recurrent active infection History peptic ulcer Patients history chronic liver disease liver disorders； ALT AST 2.5 time upper limit normal History HIV , hepatitis C hepatitis B Positive Cardiovascular cerebrovascular disease clinically significant Uncontrolled diabetes mellitus Use corticosteroid 12 week inclusion period Pregnant patient patient plan become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>